Health Catalyst Q1 revenue $74.7M, Adj EBITDA $3.4M; beats guidance mid-point

Health Catalyst, Inc.

2024-Q1 EPS reported -$0.35 revenue$74,723,000

Q1 total revenue $74.7M (up 1% YoY), net loss $20.6M (improved 38% from $33.2M loss).
Adjusted EBITDA $3.4M above Q1 guidance range of $2M-$4M.
Reiterates FY2024 revenue guidance $304M-$312M and Adj EBITDA $24M-$26M.
Q2 2024 guidance: revenue $73.5M-$76.5M, Adj EBITDA $5M-$7M.
New platform branded Health Catalyst Ignite; expansion with Saudi German Health announced.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Health Catalyst, Inc. reported the quarter ended March 31, 2024 results: revenue $74.7 million.

Period: the quarter ended March 31, 2024
Revenue: $74.7 million
Result: reported results

Exact text from the filing

today reported financial results for the quarter ended March 31, 2024. “For the first quarter of 2024, I am pleased by our strong financial results, including total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, with these results beating the mid-point of our quarterly guidance on each metric. This financial performance demonstrates our ability to

View on SEC.gov

1052 earnings releases filed in the last 30 days. Browse all earnings releases →

Health Catalyst, Inc. filing history →

Source: SEC EDGAR

accession 0001636422-24-000072

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.